investmentCypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call Prepared Remarks Transcript
SA Transcripts157.36K FollowersFollow5ShareSaveComments Cypherpunk Technologies Inc. (CYPH) Leap Therapeutics, Inc. - Shareholder/Analyst Call December 15, 2025 11:00 AM EST Company Participants Douglas Onsi - CFO, General Counsel, Treasurer & Secretary, President, CEO & Director Conference Call Participants Margaret Lloyd Presentation Douglas OnsiCFO, General Counsel, Treasurer & Secretary, President, CEO & Director Good morning, ladies and gentlemen. I'm Douglas Onsi, President and Chief Executive Officer of Cypherpunk Technologies, Inc., formerly Leap Therapeutics, Inc. It is my pleasure to welcome all of you to our virtual Special Meeting. It is 11:00 on December 15, 2025, and in accordance with the Notice of Special Meeting of Stockholders, I call to order the Special Meeting of Stockholders of Cypherpunk Technologies. On the virtual meeting platform, each stockholder has been granted access to an agenda and rules of conduct for the meeting. We will conduct the meeting in accordance with the agenda and rules of conduct. Any questions posed will be addressed following the conclusion of the meeting. The items of business before the meeting are: A proposal to amend the company's Certificate of Incorporation to increase the total number of shares that the company may issue, from 250 million shares to 500 million of shares, of which 490 million shall be designated as common stock. A proposal to authorize our Board to amend the company's Certificate of Incorporation to effect a reverse stock split at a ratio within a range of 1:5 up to 1:20, which the Board may choose to effect within 1 year of this Special Meeting in its discretion. A proposal to adopt the new 2025 Equity Incentive Plan. A proposal to permit the company, for the purpose of complying with NASDAQ listing rules, to issue shares in excess of 19.99% of the company's outstanding common stock upon the exercise of certain warrants issued to